© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Staff neurologist, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
November 04, 2021
An expert provided thoughts on the state of multiple sclerosis research, where the efforts have been directed recently, and areas that need increased focus.
November 03, 2021
An expert discussed the ways the multiple sclerosis community can create change and ultimately improve education on cannabis use.
November 01, 2021
An expert provided context on the need to improve awareness and education on cannabis for patients with multiple sclerosis.
June 21, 2021
Advice to community physicians and neurologists who play a role in caring for patients with multiple sclerosis in community practices on optimizing therapy with high-efficacy and newer treatment options.
June 14, 2021
Gaps in care that neurologists experience when treating patients with relapsing-remitting multiple sclerosis and considerations for recommending lifestyle modifications to help manage symptoms.
Exciting strategies and biomarkers being investigated to improve the evaluation and treatment of patients with relapsing-remitting multiple sclerosis.
June 07, 2021
Drs Patricia K. Coyle and Robert Fox comment on approaching multiple sclerosis relapses as early as possible with high-efficacy therapy.
Factors that may warrant a switch in therapy to treat relapsing-remitting multiple sclerosis.
June 01, 2021
Recommendations regarding how to monitor patients who receive therapy for relapsing-remitting multiple sclerosis and to conduct repeat imaging assessments appropriately.
Factors that impact treatment selection for a 25-year-old woman who presents with relapsing multiple sclerosis, including the patient’s interest in becoming pregnant.